MPPL

Maiva Pharma started operations in 1996, as a manufacturer of high quality liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles. The facility has 4 manufacturing lines which are capable of manufacturing both aseptically filled and terminally sterilized products. MAIVA has EU-GMP, Health Canada, PIC/S, USFDA, ANVISA, and WHO-GMP certification. MAIVA already owns 19 ANDA approvals US market. Maiva have capabilities to perform end to end integrated pharmaceutical development and manufacturing of sterile liquid and lyophilized vials.